Tenascin-C: A novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays

Journal of Proteome Research

Volumn 14, Issue 2, 2015, Pages 814-822

  Nie, Song ^a   Gurrea, Mikel ^a   Zhu, Jianhui ^a   Thakolwiboon, Smathorn ^a,b   Heth, Jason A ^a   Muraszko, Karin M ^a   Fan, Xing ^a   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

cancer stem cell; GBM; marker; tenascin C; tissue microarrays

Indexed keywords

CD133 ANTIGEN; TENASCIN; TUMOR MARKER;

ADULT; ARTICLE; ASTROCYTOMA; CANCER RESISTANCE; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; CELL CULTURE; CELL POPULATION; CELL SELECTION; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TISSUE MICROARRAY; TISSUE SECTION; ADOLESCENT; BRAIN TUMOR; CHEMISTRY; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PROCEDURES; TUMOR CELL CULTURE; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; TENASCIN; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84922645138     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5008653     Document Type: Article

References (53)

1. Louis, D. N.; Ohgaki, H.; Wiestler, O. D.; Cavenee, W. K.; Burger, P. C.; Jouvet, A.; Scheithauer, B. W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol. 2007, 114, 97-109
2. Quigley, M. R.; Post, C.; Ehrlich, G. Some speculation on the origin of glioblastoma Neurosurg. Rev. 2007, 30, 16-20
3. Stupp, R.; Mason, W. P.; van den Bent, M. J.; Weller, M.; Fisher, B.; Taphoorn, M. J.; Belanger, K.; Brandes, A. A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R. C.; Ludwin, S. K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J. G.; Eisenhauer, E.; Mirimanoff, R. O. Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma N. Engl. J. Med. 2005, 352, 987-96
4. Ohgaki, H.; Dessen, P.; Jourde, B.; Horstmann, S.; Nishikawa, T.; Di Patre, P. L.; Burkhard, C.; Schuler, D.; Probst-Hensch, N. M.; Maiorka, P. C.; Baeza, N.; Pisani, P.; Yonekawa, Y.; Yasargil, M. G.; Lutolf, U. M.; Kleihues, P. Genetic pathways to glioblastoma: a population-based study Cancer Res. 2004, 64, 6892-9
5. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 2006, 444, 756-60
6. Dick, J. E. Stem cell concepts renew cancer research Blood 2008, 112, 4793-807
7. Ortensi, B.; Setti, M.; Osti, D.; Pelicci, G. Cancer stem cell contribution to glioblastoma invasiveness Stem Cell Res. Ther. 2013, 4, 18
8. + cancer stem cells in glioblastoma Mol. Cancer 2006, 5, 67
9. Oliveira, L. R.; Jeffrey, S. S.; Ribeiro-Silva, A. Stem cells in human breast cancer Histol. Histopathol. 2010, 25, 371-85
10. Yi, S. Y.; Nan, K. J. Tumor-initiating stem cells in liver cancer Cancer Biol. Ther. 2008, 7, 325-30
11. Bao, Q.; Zhao, Y.; Renner, A.; Niess, H.; Seeliger, H.; Jauch, K. W.; Bruns, C. J. Cancer stem cells in pancreatic cancer Cancers 2010, 2, 1629-41
12. Soltanian, S.; Matin, M. M. Cancer stem cells and cancer therapy Tumour Biol. 2011, 32, 425-40
13. Ignatova, T. N.; Kukekov, V. G.; Laywell, E. D.; Suslov, O. N.; Vrionis, F. D.; Steindler, D. A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro Glia 2002, 39, 193-206
14. Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; De Vitis, S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res. 2004, 64, 7011-21
15. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells Nature 2004, 432, 396-401
16. Sanai, N.; Alvarez-Buylla, A.; Berger, M. S. Neural stem cells and the origin of gliomas N. Engl. J. Med. 2005, 353, 811-22
17. Piccirillo, S. G.; Reynolds, B. A.; Zanetti, N.; Lamorte, G.; Binda, E.; Broggi, G.; Brem, H.; Olivi, A.; Dimeco, F.; Vescovi, A. L. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells Nature 2006, 444, 761-5
18. Fan, X.; Khaki, L.; Zhu, T. S.; Soules, M. E.; Talsma, C. E.; Gul, N.; Koh, C.; Zhang, J.; Li, Y. M.; Maciaczyk, J.; Nikkhah, G.; Dimeco, F.; Piccirillo, S.; Vescovi, A. L.; Eberhart, C. G. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts Stem Cells 2010, 28, 5-16
19. Fan, X.; Matsui, W.; Khaki, L.; Stearns, D.; Chun, J.; Li, Y. M.; Eberhart, C. G. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors Cancer Res. 2006, 66, 7445-52
20. Bao, S.; Wu, Q.; Li, Z.; Sathornsumetee, S.; Wang, H.; McLendon, R. E.; Hjelmeland, A. B.; Rich, J. N. Targeting cancer stem cells through L1CAM suppresses glioma growth Cancer Res. 2008, 68, 6043-8
21. Yan, X.; Ma, L.; Yi, D.; Yoon, J. G.; Diercks, A.; Foltz, G.; Price, N. D.; Hood, L. E.; Tian, Q. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 1591-6
22. Goidts, V.; Bageritz, J.; Puccio, L.; Nakata, S.; Zapatka, M.; Barbus, S.; Toedt, G.; Campos, B.; Korshunov, A.; Momma, S.; Van Schaftingen, E.; Reifenberger, G.; Herold-Mende, C.; Lichter, P.; Radlwimmer, B. RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival Oncogene 2012, 31, 3235-43
23. He, J.; Liu, Y.; Zhu, T.; Zhu, J.; Dimeco, F.; Vescovi, A. L.; Heth, J. A.; Muraszko, K. M.; Fan, X.; Lubman, D. M. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays Mol. Cell. Proteomics 2011, 11, M111.010744
24. + glioblastoma stem cells derived from treatment-refractory recurrent brain tumors J. Neurooncol. 2009, 94, 1-19
25. - metastatic colon cancer cells initiate tumors J. Clin. Invest. 2008, 118, 2111-20
26. Wan, F.; Zhang, S.; Xie, R.; Gao, B.; Campos, B.; Herold-Mende, C.; Lei, T. The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research Brain Pathol. 2010, 20, 877-89
27. Wang, J.; Sakariassen, P. O.; Tsinkalovsky, O.; Immervoll, H.; Boe, S. O.; Svendsen, A.; Prestegarden, L.; Rosland, G.; Thorsen, F.; Stuhr, L.; Molven, A.; Bjerkvig, R.; Enger, P. O. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells Int. J. Cancer 2008, 122, 761-8
28. Joo, K. M.; Kim, S. Y.; Jin, X.; Song, S. Y.; Kong, D. S.; Lee, J. I.; Jeon, J. W.; Kim, M. H.; Kang, B. G.; Jung, Y.; Jin, J.; Hong, S. C.; Park, W. Y.; Lee, D. S.; Kim, H.; Nam, D. H. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas Lab. Invest. 2008, 88, 808-15
29. Svendsen, A.; Verhoeff, J. J.; Immervoll, H.; Brogger, J. C.; Kmiecik, J.; Poli, A.; Netland, I. A.; Prestegarden, L.; Planaguma, J.; Torsvik, A.; Kjersem, A. B.; Sakariassen, P. O.; Heggdal, J. I.; Van Furth, W. R.; Bjerkvig, R.; Lund-Johansen, M.; Enger, P. O.; Felsberg, J.; Brons, N. H.; Tronstad, K. J.; Waha, A.; Chekenya, M. Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma Acta Neuropathol. 2011, 122, 495-510
30. Read, T. A.; Fogarty, M. P.; Markant, S. L.; McLendon, R. E.; Wei, Z.; Ellison, D. W.; Febbo, P. G.; Wechsler-Reya, R. J. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma Cancer Cell 2009, 15, 135-47
31. Jones, F. S.; Jones, P. L. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling Dev. Dyn. 2000, 218, 235-59
32. Midwood, K. S.; Hussenet, T.; Langlois, B.; Orend, G. Advances in tenascin-C biology Cell. Mol. Life Sci. 2011, 68, 3175-99
33. Bourdon, M. A.; Wikstrand, C. J.; Furthmayr, H.; Matthews, T. J.; Bigner, D. D. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody Cancer Res. 1983, 43, 2796-805
34. Behrem, S.; Zarkovic, K.; Eskinja, N.; Jonjic, N. Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation Pathol. Oncol. Res. 2005, 11, 229-35
35. Jurga, M.; Lipkowski, A. W.; Lukomska, B.; Buzanska, L.; Kurzepa, K.; Sobanski, T.; Habich, A.; Coecke, S.; Gajkowska, B.; Domanska-Janik, K. Generation of functional neural artificial tissue from human umbilical cord blood stem cells Tissue Eng., Part C 2009, 15, 365-72
36. von Holst, A. Tenascin C in stem cell niches: redundant, permissive or instructive? Cells Tissues Organs 2008, 188, 170-7
37. Rolle, K.; Nowak, S.; Wyszko, E.; Nowak, M.; Zukiel, R.; Piestrzeniewicz, R.; Gawronska, I.; Barciszewska, M. Z.; Barciszewski, J. Promising human brain tumors therapy with interference RNA intervention (iRNAi) Cancer Biol. Ther. 2010, 9, 396-406
38. He, J.; Liu, Y.; Xie, X.; Zhu, T.; Soules, M.; DiMeco, F.; Vescovi, A. L.; Fan, X.; Lubman, D. M. Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach J. Proteome Res. 2010, 9, 2565-72
39. + neuroblastoma cells serve as progenitors of tumor-derived endothelial cells Cell Res. 2011, 21, 1470-86
40. Zhu, T. S.; Costello, M. A.; Talsma, C. E.; Flack, C. G.; Crowley, J. G.; Hamm, L. L.; He, X.; Hervey-Jumper, S. L.; Heth, J. A.; Muraszko, K. M.; DiMeco, F.; Vescovi, A. L.; Fan, X. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells Cancer Res. 2011, 71, 6061-72
41. Bar, E. E.; Chaudhry, A.; Lin, A.; Fan, X.; Schreck, K.; Matsui, W.; Piccirillo, S.; Vescovi, A. L.; DiMeco, F.; Olivi, A.; Eberhart, C. G. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma Stem Cells 2007, 25, 2524-33
42. He, J.; Liu, Y.; Zhu, T. S.; Xie, X.; Costello, M. A.; Talsma, C. E.; Flack, C. G.; Crowley, J. G.; Dimeco, F.; Vescovi, A. L.; Fan, X.; Lubman, D. M. Glycoproteomic analysis of glioblastoma stem cell differentiation J. Proteome Res. 2011, 10, 330-8
43. Bidlingmaier, S.; Zhu, X.; Liu, B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells J. Mol. Med. 2008, 86, 1025-32
44. - glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles Cancer Res. 2007, 67, 4010-5
45. Jaksch, M.; Munera, J.; Bajpai, R.; Terskikh, A.; Oshima, R. G. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines Cancer Res. 2008, 68, 7882-6
46. Gilbertson, R. J.; Rich, J. N. Making a tumour's bed: glioblastoma stem cells and the vascular niche Nat. Rev. Cancer 2007, 7, 733-6
47. Hau, P.; Kunz-Schughart, L. A.; Rummele, P.; Arslan, F.; Dorfelt, A.; Koch, H.; Lohmeier, A.; Hirschmann, B.; Muller, A.; Bogdahn, U.; Bosserhoff, A. K. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas J. Neurooncol. 2006, 77, 1-7
48. Garcion, E.; Halilagic, A.; Faissner, A.; ffrench-Constant, C. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C Development 2004, 131, 3423-32
49. Leins, A.; Riva, P.; Lindstedt, R.; Davidoff, M. S.; Mehraein, P.; Weis, S. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma Cancer 2003, 98, 2430-9
50. Piccirillo, S. G.; Combi, R.; Cajola, L.; Patrizi, A.; Redaelli, S.; Bentivegna, A.; Baronchelli, S.; Maira, G.; Pollo, B.; Mangiola, A.; DiMeco, F.; Dalpra, L.; Vescovi, A. L. Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution Oncogene 2009, 28, 1807-11
51. Didem, T.; Faruk, T.; Senem, K.; Derya, D.; Murat, S.; Murat, G.; Oznur, K. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer Tumour Biol. 2014, 35, 6777-82
52. Yamauchi, M.; Mizuhara, Y.; Maezawa, Y.; Toda, G. Serum tenascin levels in chronic liver disease Liver 1994, 14, 148-53
53. Nishio, T.; Kawaguchi, S.; Iseda, T.; Kawasaki, T.; Hase, T. Secretion of tenascin-C by cultured astrocytes: regulation of cell proliferation and process elongation Brain Res. 2003, 990, 129-40